Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Cancer Cell International
Published in: Cancer Cell International 1/2011

Open Access 01-12-2011 | Review

Translesion DNA synthesis in the context of cancer research

Authors: Philip A Knobel, Thomas M Marti

Published in: Cancer Cell International | Issue 1/2011

Login to get access

Abstract

During cell division, replication of the genomic DNA is performed by high-fidelity DNA polymerases but these error-free enzymes can not synthesize across damaged DNA. Specialized DNA polymerases, so called DNA translesion synthesis polymerases (TLS polymerases), can replicate damaged DNA thereby avoiding replication fork breakdown and subsequent chromosomal instability.
We focus on the involvement of mammalian TLS polymerases in DNA damage tolerance mechanisms. In detail, we review the discovery of TLS polymerases and describe the molecular features of all the mammalian TLS polymerases identified so far. We give a short overview of the mechanisms that regulate the selectivity and activity of TLS polymerases. In addition, we summarize the current knowledge how different types of DNA damage, relevant either for the induction or treatment of cancer, are bypassed by TLS polymerases. Finally, we elucidate the relevance of TLS polymerases in the context of cancer therapy.
Appendix
Available only for authorised users
Literature
1.
Lander ES, Linton LM, Birren B, Nusbaum C, Zody MC, Baldwin J, Devon K, Dewar K, Doyle M, FitzHugh W: Initial sequencing and analysis of the human genome. Nature. 2001, 409 (6822): 860-921.PubMed
2.
Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA: The sequence of the human genome. Science. 2001, 291 (5507): 1304-1351.PubMed
3.
Lindahl T, Barnes DE: Repair of endogenous DNA damage. Cold Spring Harb Symp Quant Biol. 2000, 65: 127-133.PubMed
4.
Barnes DE, Lindahl T: Repair and genetic consequences of endogenous DNA base damage in mammalian cells. Annu Rev Genet. 2004, 38: 445-476.PubMed
5.
Hecht SS: Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999, 91 (14): 1194-1210.PubMed
6.
Zamble DB, Lippard SJ: Cisplatin and DNA repair in cancer chemotherapy. Trends Biochem Sci. 1995, 20 (10): 435-439.PubMed
7.
Aguilera A, Gomez-Gonzalez B: Genome instability: a mechanistic view of its causes and consequences. Nat Rev Genet. 2008, 9 (3): 204-217.PubMed
8.
Chuang PT, Kawcak T, McMahon AP: Feedback control of mammalian Hedgehog signaling by the Hedgehog-binding protein, Hip1, modulates Fgf signaling during branching morphogenesis of the lung. Genes Dev. 2003, 17 (3): 342-347.PubMedCentralPubMed
9.
van der Wilt CL, Backus HH, Smid K, Comijn L, Veerman G, Wouters D, Voorn DA, Priest DG, Bunni MA, Mitchell F: Modulation of both endogenous folates and thymidine enhance the therapeutic efficacy of thymidylate synthase inhibitors. Cancer Res. 2001, 61 (9): 3675-3681.PubMed
10.
Lee GH, Nishimori H, Sasaki Y, Matsushita H, Kitagawa T, Tokino T: Analysis of lung tumorigenesis in chimeric mice indicates the Pulmonary adenoma resistance 2 (Par2) locus to operate in the tumor-initiation stage in a cell-autonomous manner: detection of polymorphisms in the Poli gene as a candidate for Par2. Oncogene. 2003, 22 (15): 2374-2382.PubMed
11.
Broomfield S, Hryciw T, Xiao W: DNA postreplication repair and mutagenesis in Saccharomyces cerevisiae. Mutation research. 2001, 486 (3): 167-184.PubMed
12.
Bessman MJ, Kornberg A, Lehman IR, Simms ES: Enzymic synthesis of deoxyribonucleic acid. Biochimica et biophysica acta. 1956, 21 (1): 197-198.PubMed
13.
Goulian M, Kornberg A: Enzymatic synthesis of DNA. 23. Synthesis of circular replicative form of phage phi-X174 DNA. Proc Natl Acad Sci USA. 1967, 58 (4): 1723-1730.PubMedCentralPubMed
14.
Goulian M, Kornberg A, Sinsheimer RL: Enzymatic synthesis of DNA, XXIV. Synthesis of infectious phage phi-X174 DNA. Proc Natl Acad Sci USA. 1967, 58 (6): 2321-2328.PubMedCentralPubMed
15.
Kornberg T, Gefter ML: DNA synthesis in cell-free extracts of a DNA polymerase-defective mutant. Biochem Biophys Res Commun. 1970, 40 (6): 1348-1355.PubMed
16.
Kornberg T, Gefter ML: Purification and DNA synthesis in cell-free extracts: properties of DNA polymerase II. Proc Natl Acad Sci USA. 1971, 68 (4): 761-764.PubMedCentralPubMed
17.
Kornberg T, Gefter ML: Deoxyribonucleic acid synthesis in cell-free extracts. IV. Purification and catalytic properties of deoxyribonucleic acid polymerase III. J Biol Chem. 1972, 247 (17): 5369-5375.PubMed
18.
George J, Devoret R, Radman M: Indirect ultraviolet-reactivation of phage lambda. Proc Natl Acad Sci USA. 1974, 71 (1): 144-147.PubMedCentralPubMed
19.
20.
Kato T, Shinoura Y: Isolation and characterization of mutants of Escherichia coli deficient in induction of mutations by ultraviolet light. Mol Gen Genet. 1977, 156 (2): 121-131.PubMed
21.
Lawrence CW, Das G, Christensen RB: REV7, a new gene concerned with UV mutagenesis in yeast. Mol Gen Genet. 1985, 200 (1): 80-85.PubMed
22.
Bonner CA, Hays S, McEntee K, Goodman MF: DNA polymerase II is encoded by the DNA damage-inducible dinA gene of Escherichia coli. Proc Natl Acad Sci USA. 1990, 87 (19): 7663-7667.PubMedCentralPubMed
23.
Iwasaki H, Nakata A, Walker GC, Shinagawa H: The Escherichia coli polB gene, which encodes DNA polymerase II, is regulated by the SOS system. J Bacteriol. 1990, 172 (11): 6268-6273.PubMedCentralPubMed
24.
Kenyon CJ, Walker GC: DNA-damaging agents stimulate gene expression at specific loci in Escherichia coli. Proc Natl Acad Sci USA. 1980, 77 (5): 2819-2823.PubMedCentralPubMed
25.
Wagner J, Gruz P, Kim SR, Yamada M, Matsui K, Fuchs RP, Nohmi T: The dinB gene encodes a novel E. coli DNA polymerase, DNA pol IV, involved in mutagenesis. Molecular cell. 1999, 4 (2): 281-286.PubMed
26.
Tang M, Shen X, Frank EG, O'Donnell M, Woodgate R, Goodman MF: UmuD'(2)C is an error-prone DNA polymerase, Escherichia coli pol V. Proc Natl Acad Sci USA. 1999, 96 (16): 8919-8924.PubMedCentralPubMed
27.
Reuven NB, Arad G, Maor-Shoshani A, Livneh Z: The mutagenesis protein UmuC is a DNA polymerase activated by UmuD', RecA, and SSB and is specialized for translesion replication. J Biol Chem. 1999, 274 (45): 31763-31766.PubMed
28.
Tang M, Pham P, Shen X, Taylor JS, O'Donnell M, Woodgate R, Goodman MF: Roles of E. coli DNA polymerases IV and V in lesion-targeted and untargeted SOS mutagenesis. Nature. 2000, 404 (6781): 1014-1018.PubMed
29.
McDonald JP, Levine AS, Woodgate R: The Saccharomyces cerevisiae RAD30 gene, a homologue of Escherichia coli dinB and umuC, is DNA damage inducible and functions in a novel error-free postreplication repair mechanism. Genetics. 1997, 147 (4): 1557-1568.PubMedCentralPubMed
30.
Sharief FS, Vojta PJ, Ropp PA, Copeland WC: Cloning and chromosomal mapping of the human DNA polymerase theta (POLQ), the eighth human DNA polymerase. Genomics. 1999, 59 (1): 90-96.PubMed
31.
Gerlach VL, Aravind L, Gotway G, Schultz RA, Koonin EV, Friedberg EC: Human and mouse homologs of Escherichia coli DinB (DNA polymerase IV), members of the UmuC/DinB superfamily. Proc Natl Acad Sci USA. 1999, 96 (21): 11922-11927.PubMedCentralPubMed
32.
McDonald JP, Rapic-Otrin V, Epstein JA, Broughton BC, Wang X, Lehmann AR, Wolgemuth DJ, Woodgate R: Novel human and mouse homologs of Saccharomyces cerevisiae DNA polymerase eta. Genomics. 1999, 60 (1): 20-30.PubMed
33.
Aoufouchi S, Flatter E, Dahan A, Faili A, Bertocci B, Storck S, Delbos F, Cocea L, Gupta N, Weill JC: Two novel human and mouse DNA polymerases of the polX family. Nucleic acids research. 2000, 28 (18): 3684-3693.PubMedCentralPubMed
34.
Dominguez O, Ruiz JF, Lain de Lera T, Garcia-Diaz M, Gonzalez MA, Kirchhoff T, Martinez AC, Bernad A, Blanco L: DNA polymerase mu (Pol mu), homologous to TdT, could act as a DNA mutator in eukaryotic cells. The EMBO journal. 2000, 19 (7): 1731-1742.PubMedCentralPubMed
35.
Garcia-Diaz M, Dominguez O, Lopez-Fernandez LA, de Lera LT, Saniger ML, Ruiz JF, Parraga M, Garcia-Ortiz MJ, Kirchhoff T, del Mazo J: DNA polymerase lambda (Pol lambda), a novel eukaryotic DNA polymerase with a potential role in meiosis. J Mol Biol. 2000, 301 (4): 851-867.PubMed
36.
Marini F, Kim N, Schuffert A, Wood RD: POLN, a nuclear PolA family DNA polymerase homologous to the DNA cross-link sensitivity protein Mus308. J Biol Chem. 2003, 278 (34): 32014-32019.PubMed
37.
Nelson JR, Lawrence CW, Hinkle DC: Thymine-thymine dimer bypass by yeast DNA polymerase zeta. Science. 1996, 272 (5268): 1646-1649.PubMed
38.
Nelson JR, Lawrence CW, Hinkle DC: Deoxycytidyl transferase activity of yeast REV1 protein. Nature. 1996, 382 (6593): 729-731.PubMed
39.
Lawrence CW: Cellular roles of DNA polymerase zeta and Rev1 protein. DNA repair. 2002, 1 (6): 425-435.PubMed
40.
Lin W, Xin H, Zhang Y, Wu X, Yuan F, Wang Z: The human REV1 gene codes for a DNA template-dependent dCMP transferase. Nucleic acids research. 1999, 27 (22): 4468-4475.PubMedCentralPubMed
41.
Kannouche P, Stary A: Xeroderma pigmentosum variant and error-prone DNA polymerases. Biochimie. 2003, 85 (11): 1123-1132.PubMed
42.
Maher VM, Ouellette LM, Curren RD, McCormick JJ: Frequency of ultraviolet light-induced mutations is higher in xeroderma pigmentosum variant cells than in normal human cells. Nature. 1976, 261 (5561): 593-595.PubMed
43.
Johnson RE, Washington MT, Haracska L, Prakash S, Prakash L: Eukaryotic polymerases iota and zeta act sequentially to bypass DNA lesions. Nature. 2000, 406 (6799): 1015-1019.PubMed
44.
Washington MT, Minko IG, Johnson RE, Wolfle WT, Harris TM, Lloyd RS, Prakash S, Prakash L: Efficient and error-free replication past a minor-groove DNA adduct by the sequential action of human DNA polymerases iota and kappa. Mol Cell Biol. 2004, 24 (13): 5687-5693.PubMedCentralPubMed
45.
Ogi T, Shinkai Y, Tanaka K, Ohmori H: Polkappa protects mammalian cells against the lethal and mutagenic effects of benzo[a]pyrene. Proc Natl Acad Sci USA. 2002, 99 (24): 15548-15553.PubMedCentralPubMed
46.
Arana ME, Seki M, Wood RD, Rogozin IB, Kunkel TA: Low-fidelity DNA synthesis by human DNA polymerase theta. Nucleic acids research. 2008, 36 (11): 3847-3856.PubMedCentralPubMed
47.
Masuda K, Ouchida R, Takeuchi A, Saito T, Koseki H, Kawamura K, Tagawa M, Tokuhisa T, Azuma T, J OW: DNA polymerase theta contributes to the generation of C/G mutations during somatic hypermutation of Ig genes. Proc Natl Acad Sci USA. 2005, 102 (39): 13986-13991.PubMedCentralPubMed
48.
Zan H, Shima N, Xu Z, Al-Qahtani A, Evinger Iii AJ, Zhong Y, Schimenti JC, Casali P: The translesion DNA polymerase theta plays a dominant role in immunoglobulin gene somatic hypermutation. The EMBO journal. 2005, 24 (21): 3757-3769.PubMedCentralPubMed
49.
Bertocci B, De Smet A, Weill JC, Reynaud CA: Nonoverlapping functions of DNA polymerases mu, lambda, and terminal deoxynucleotidyltransferase during immunoglobulin V(D)J recombination in vivo. Immunity. 2006, 25 (1): 31-41.PubMed
50.
Bertocci B, De Smet A, Berek C, Weill JC, Reynaud CA: Immunoglobulin kappa light chain gene rearrangement is impaired in mice deficient for DNA polymerase mu. Immunity. 2003, 19 (2): 203-211.PubMed
51.
Takata K, Shimizu T, Iwai S, Wood RD: Human DNA polymerase N (POLN) is a low fidelity enzyme capable of error-free bypass of 5S-thymine glycol. J Biol Chem. 2006, 281 (33): 23445-23455.PubMed
52.
Stallons LJ, McGregor WG: Translesion synthesis polymerases in the prevention and promotion of carcinogenesis. J Nucleic Acids. 2010, 2010:
53.
Boudsocq F, Kokoska RJ, Plosky BS, Vaisman A, Ling H, Kunkel TA, Yang W, Woodgate R: Investigating the role of the little finger domain of Y-family DNA polymerases in low fidelity synthesis and translesion replication. J Biol Chem. 2004, 279 (31): 32932-32940.PubMed
54.
Fortune JM, Stith CM, Kissling GE, Burgers PM, Kunkel TA: RPA and PCNA suppress formation of large deletion errors by yeast DNA polymerase delta. Nucleic acids research. 2006, 34 (16): 4335-4341.PubMedCentralPubMed
55.
Kunkel TA: DNA replication fidelity. J Biol Chem. 2004, 279 (17): 16895-16898.PubMed
56.
McCulloch SD, Kunkel TA: The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases. Cell Res. 2008, 18 (1): 148-161.PubMedCentralPubMed
57.
Gibbs PE, McDonald J, Woodgate R, Lawrence CW: The relative roles in vivo of Saccharomyces cerevisiae Pol eta, Pol zeta, Rev1 protein and Pol32 in the bypass and mutation induction of an abasic site, T-T (6-4) photoadduct and T-T cis-syn cyclobutane dimer. Genetics. 2005, 169 (2): 575-582.PubMedCentralPubMed
58.
Washington MT, Johnson RE, Prakash S, Prakash L: Accuracy of thymine-thymine dimer bypass by Saccharomyces cerevisiae DNA polymerase eta. Proc Natl Acad Sci USA. 2000, 97 (7): 3094-3099.PubMedCentralPubMed
59.
Cordonnier AM, Fuchs RP: Replication of damaged DNA: molecular defect in xeroderma pigmentosum variant cells. Mutation research. 1999, 435 (2): 111-119.PubMed
60.
Yamada A, Masutani C, Iwai S, Hanaoka F: Complementation of defective translesion synthesis and UV light sensitivity in xeroderma pigmentosum variant cells by human and mouse DNA polymerase eta. Nucleic acids research. 2000, 28 (13): 2473-2480.PubMedCentralPubMed
61.
Roush AA, Suarez M, Friedberg EC, Radman M, Siede W: Deletion of the Saccharomyces cerevisiae gene RAD30 encoding an Escherichia coli DinB homolog confers UV radiation sensitivity and altered mutability. Mol Gen Genet. 1998, 257 (6): 686-692.PubMed
62.
Seki M, Masutani C, Yang LW, Schuffert A, Iwai S, Bahar I, Wood RD: High-efficiency bypass of DNA damage by human DNA polymerase Q. The EMBO journal. 2004, 23 (22): 4484-4494.PubMedCentralPubMed
63.
Yoshimura M, Kohzaki M, Nakamura J, Asagoshi K, Sonoda E, Hou E, Prasad R, Wilson SH, Tano K, Yasui A: Vertebrate POLQ and POLbeta cooperate in base excision repair of oxidative DNA damage. Molecular cell. 2006, 24 (1): 115-125.PubMedCentralPubMed
64.
Shachar S, Ziv O, Avkin S, Adar S, Wittschieben J, Reissner T, Chaney S, Friedberg EC, Wang Z, Carell T: Two-polymerase mechanisms dictate error-free and error-prone translesion DNA synthesis in mammals. The EMBO journal. 2009, 28 (4): 383-393.PubMedCentralPubMed
65.
Ohmori H, Friedberg EC, Fuchs RP, Goodman MF, Hanaoka F, Hinkle D, Kunkel TA, Lawrence CW, Livneh Z, Nohmi T: The Y-family of DNA polymerases. Molecular cell. 2001, 8 (1): 7-8.PubMed
66.
Gibbs PE, McGregor WG, Maher VM, Nisson P, Lawrence CW: A human homolog of the Saccharomyces cerevisiae REV3 gene, which encodes the catalytic subunit of DNA polymerase zeta. Proc Natl Acad Sci USA. 1998, 95 (12): 6876-6880.PubMedCentralPubMed
67.
Lin W, Wu X, Wang Z: A full-length cDNA of hREV3 is predicted to encode DNA polymerase zeta for damage-induced mutagenesis in humans. Mutation research. 1999, 433 (2): 89-98.PubMed
68.
Seki M, Marini F, Wood RD: POLQ (Pol theta), a DNA polymerase and DNA-dependent ATPase in human cells. Nucleic acids research. 2003, 31 (21): 6117-6126.PubMedCentralPubMed
69.
Prasad R, Longley MJ, Sharief FS, Hou EW, Copeland WC, Wilson SH: Human DNA polymerase theta possesses 5'-dRP lyase activity and functions in single-nucleotide base excision repair in vitro. Nucleic acids research. 2009, 37 (6): 1868-1877.PubMedCentralPubMed
70.
Seki M, Wood RD: DNA polymerase theta (POLQ) can extend from mismatches and from bases opposite a (6-4) photoproduct. DNA repair. 2008, 7 (1): 119-127.PubMedCentralPubMed
71.
Maga G, Shevelev I, Ramadan K, Spadari S, Hubscher U: DNA polymerase theta purified from human cells is a high-fidelity enzyme. J Mol Biol. 2002, 319 (2): 359-369.PubMed
72.
Shima N, Munroe RJ, Schimenti JC: The mouse genomic instability mutation chaos1 is an allele of Polq that exhibits genetic interaction with Atm. Mol Cell Biol. 2004, 24 (23): 10381-10389.PubMedCentralPubMed
73.
Shima N, Hartford SA, Duffy T, Wilson LA, Schimenti KJ, Schimenti JC: Phenotype-based identification of mouse chromosome instability mutants. Genetics. 2003, 163 (3): 1031-1040.PubMedCentralPubMed
74.
Ukai A, Maruyama T, Mochizuki S, Ouchida R, Masuda K, Kawamura K, Tagawa M, Kinoshita K, Sakamoto A, Tokuhisa T: Role of DNA polymerase theta in tolerance of endogenous and exogenous DNA damage in mouse B cells. Genes Cells. 2006, 11 (2): 111-121.PubMed
75.
Shivapurkar N, Sood S, Wistuba II, Virmani AK, Maitra A, Milchgrub S, Minna JD, Gazdar AF: Multiple regions of chromosome 4 demonstrating allelic losses in breast carcinomas. Cancer Res. 1999, 59 (15): 3576-3580.PubMed
76.
Zietlow L, Smith LA, Bessho M, Bessho T: Evidence for the involvement of human DNA polymerase N in the repair of DNA interstrand cross-links. Biochemistry. 2009, 48 (49): 11817-11824.PubMedCentralPubMed
77.
Moldovan GL, Madhavan MV, Mirchandani KD, McCaffrey RM, Vinciguerra P, D'Andrea AD: DNA polymerase POLN participates in cross-link repair and homologous recombination. Mol Cell Biol. 2010, 30 (4): 1088-1096.PubMedCentralPubMed
78.
Kohzaki M, Nishihara K, Hirota K, Sonoda E, Yoshimura M, Ekino S, Butler JE, Watanabe M, Halazonetis TD, Takeda S: DNA polymerases nu and theta are required for efficient immunoglobulin V gene diversification in chicken. The Journal of cell biology. 2010, 189 (7): 1117-1127.PubMedCentralPubMed
79.
Morrison A, Christensen RB, Alley J, Beck AK, Bernstine EG, Lemontt JF, Lawrence CW: REV3, a Saccharomyces cerevisiae gene whose function is required for induced mutagenesis, is predicted to encode a nonessential DNA polymerase. J Bacteriol. 1989, 171 (10): 5659-5667.PubMedCentralPubMed
80.
Braithwaite DK, Ito J: Compilation, alignment, and phylogenetic relationships of DNA polymerases. Nucleic acids research. 1993, 21 (4): 787-802.PubMedCentralPubMed
81.
Murakumo Y, Roth T, Ishii H, Rasio D, Numata S, Croce CM, Fishel R: A human REV7 homolog that interacts with the polymerase zeta catalytic subunit hREV3 and the spindle assembly checkpoint protein hMAD2. J Biol Chem. 2000, 275 (6): 4391-4397.PubMed
82.
Murakumo Y: The property of DNA polymerase zeta: REV7 is a putative protein involved in translesion DNA synthesis and cell cycle control. Mutation research. 2002, 510 (1-2): 37-44.PubMed
83.
Morelli C, Mungall AJ, Negrini M, Barbanti-Brodano G, Croce CM: Alternative splicing, genomic structure, and fine chromosome localization of REV3L. Cytogenet Cell Genet. 1998, 83 (1-2): 18-20.PubMed
84.
Van Sloun PP, Romeijn RJ, Eeken JC: Molecular cloning, expression and chromosomal localisation of the mouse Rev3l gene, encoding the catalytic subunit of polymerase zeta. Mutation research. 1999, 433 (2): 109-116.PubMed
85.
Morelli C, Karayianni E, Magnanini C, Mungall AJ, Thorland E, Negrini M, Smith DI, Barbanti-Brodano G: Cloning and characterization of the common fragile site FRA6F harboring a replicative senescence gene and frequently deleted in human tumors. Oncogene. 2002, 21 (47): 7266-7276.PubMed
86.
Ogawara D, Muroya T, Yamauchi K, Iwamoto TA, Yagi Y, Yamashita Y, Waga S, Akiyama M, Maki H: Near-full-length REV3L appears to be a scarce maternal factor in Xenopus laevis eggs that changes qualitatively in early embryonic development. DNA repair. 9 (1): 90-95.
87.
J OW, Kajiwara K, Kawamura K, Kimura M, Miyagishima H, Koseki H, Tagawa M: An essential role for REV3 in mammalian cell survival: absence of REV3 induces p53-independent embryonic death. Biochem Biophys Res Commun. 2002, 293 (3): 1132-1137.
88.
Esposito G, Godindagger I, Klein U, Yaspo ML, Cumano A, Rajewsky K: Disruption of the Rev3l-encoded catalytic subunit of polymerase zeta in mice results in early embryonic lethality. Curr Biol. 2000, 10 (19): 1221-1224.PubMed
89.
Wittschieben J, Shivji MK, Lalani E, Jacobs MA, Marini F, Gearhart PJ, Rosewell I, Stamp G, Wood RD: Disruption of the developmentally regulated Rev3l gene causes embryonic lethality. Curr Biol. 2000, 10 (19): 1217-1220.PubMed
90.
Bemark M, Khamlichi AA, Davies SL, Neuberger MS: Disruption of mouse polymerase zeta (Rev3) leads to embryonic lethality and impairs blastocyst development in vitro. Curr Biol. 2000, 10 (19): 1213-1216.PubMed
91.
Holway AH, Kim SH, La Volpe A, Michael WM: Checkpoint silencing during the DNA damage response in Caenorhabditis elegans embryos. The Journal of cell biology. 2006, 172 (7): 999-1008.PubMedCentralPubMed
92.
Wittschieben JP, Reshmi SC, Gollin SM, Wood RD: Loss of DNA polymerase zeta causes chromosomal instability in mammalian cells. Cancer Res. 2006, 66 (1): 134-142.PubMed
93.
Zander L, Bemark M: Immortalized mouse cell lines that lack a functional Rev3 gene are hypersensitive to UV irradiation and cisplatin treatment. DNA repair. 2004, 3 (7): 743-752.PubMed
94.
Krieg AJ, Hammond EM, Giaccia AJ: Functional analysis of p53 binding under differential stresses. Mol Cell Biol. 2006, 26 (19): 7030-7045.PubMedCentralPubMed
95.
Wu F, Lin X, Okuda T, Howell SB: DNA polymerase zeta regulates cisplatin cytotoxicity, mutagenicity, and the rate of development of cisplatin resistance. Cancer Res. 2004, 64 (21): 8029-8035.PubMed
96.
Rajpal DK, Wu X, Wang Z: Alteration of ultraviolet-induced mutagenesis in yeast through molecular modulation of the REV3 and REV7 gene expression. Mutation research. 2000, 461 (2): 133-143.PubMed
97.
Brondello JM, Pillaire MJ, Rodriguez C, Gourraud PA, Selves J, Cazaux C, Piette J: Novel evidences for a tumor suppressor role of Rev3, the catalytic subunit of Pol zeta. Oncogene. 2008, 27 (47): 6093-6101.PubMed
98.
Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, Hurov KE, Luo J, Bakalarski CE, Zhao Z, Solimini N, Lerenthal Y: ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science. 2007, 316 (5828): 1160-1166.PubMed
99.
Wittschieben JP, Patil V, Glushets V, Robinson LJ, Kusewitt DF, Wood RD: Loss of DNA Polymerase {zeta} Enhances Spontaneous Tumorigenesis. Cancer Res.
100.
Li Z, Zhang H, McManus TP, McCormick JJ, Lawrence CW, Maher VM: hREV3 is essential for error-prone translesion synthesis past UV or benzo[a]pyrene diol epoxide-induced DNA lesions in human fibroblasts. Mutation research. 2002, 510 (1-2): 71-80.PubMed
101.
Diaz M, Watson NB, Turkington G, Verkoczy LK, Klinman NR, McGregor WG: Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta. Mol Cancer Res. 2003, 1 (11): 836-847.PubMed
102.
Xie K, Doles J, Hemann MT, Walker GC: Error-prone translesion synthesis mediates acquired chemoresistance. Proc Natl Acad Sci USA. 2010, 107 (48): 20792-20797.PubMedCentralPubMed
103.
Doles J, Oliver TG, Cameron ER, Hsu G, Jacks T, Walker GC, Hemann MT: Suppression of Rev3, the catalytic subunit of Pol{zeta}, sensitizes drug-resistant lung tumors to chemotherapy. Proc Natl Acad Sci USA. 2010, 107 (48): 20786-20791.PubMedCentralPubMed
104.
Zhang N, Liu X, Li L, Legerski R: Double-strand breaks induce homologous recombinational repair of interstrand cross-links via cooperation of MSH2, ERCC1-XPF, REV3, and the Fanconi anemia pathway. DNA repair. 2007, 6 (11): 1670-1678.PubMedCentralPubMed
105.
Hicks JK, Chute CL, Paulsen MT, Ragland RL, Howlett NG, Gueranger Q, Glover TW, Canman CE: Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links. Mol Cell Biol. 2010, 30 (5): 1217-1230.PubMedCentralPubMed
106.
Schenten D, Kracker S, Esposito G, Franco S, Klein U, Murphy M, Alt FW, Rajewsky K: Pol zeta ablation in B cells impairs the germinal center reaction, class switch recombination, DNA break repair, and genome stability. J Exp Med. 2009, 206 (2): 477-490.PubMedCentralPubMed
107.
Murakumo Y, Ogura Y, Ishii H, Numata S, Ichihara M, Croce CM, Fishel R, Takahashi M: Interactions in the error-prone postreplication repair proteins hREV1, hREV3, and hREV7. J Biol Chem. 2001, 276 (38): 35644-35651.PubMed
108.
Aravind L, Koonin EV: The HORMA domain: a common structural denominator in mitotic checkpoints, chromosome synapsis and DNA repair. Trends Biochem Sci. 1998, 23 (8): 284-286.PubMed
109.
Pfleger CM, Salic A, Lee E, Kirschner MW: Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating Cdh1. Genes Dev. 2001, 15 (14): 1759-1764.PubMedCentralPubMed
110.
Iwai H, Kim M, Yoshikawa Y, Ashida H, Ogawa M, Fujita Y, Muller D, Kirikae T, Jackson PK, Kotani S: A bacterial effector targets Mad2L2, an APC inhibitor, to modulate host cell cycling. Cell. 2007, 130 (4): 611-623.PubMed
111.
McBride OW, Kozak CA, Wilson SH: Mapping of the gene for DNA polymerase beta to mouse chromosome 8. Cytogenet Cell Genet. 1990, 53 (2-3): 108-111.PubMed
112.
Kumar A, Widen SG, Williams KR, Kedar P, Karpel RL, Wilson SH: Studies of the domain structure of mammalian DNA polymerase beta. Identification of a discrete template binding domain. J Biol Chem. 1990, 265 (4): 2124-2131.PubMed
113.
Casas-Finet JR, Kumar A, Morris G, Wilson SH, Karpel RL: Spectroscopic studies of the structural domains of mammalian DNA beta-polymerase. J Biol Chem. 1991, 266 (29): 19618-19625.PubMed
114.
Pelletier H, Sawaya MR, Kumar A, Wilson SH, Kraut J: Structures of ternary complexes of rat DNA polymerase beta, a DNA template-primer, and ddCTP. Science. 1994, 264 (5167): 1891-1903.PubMed
115.
Beard WA, Shock DD, Yang XP, DeLauder SF, Wilson SH: Loss of DNA polymerase beta stacking interactions with templating purines, but not pyrimidines, alters catalytic efficiency and fidelity. J Biol Chem. 2002, 277 (10): 8235-8242.PubMed
116.
Singhal RK, Wilson SH: Short gap-filling synthesis by DNA polymerase beta is processive. J Biol Chem. 1993, 268 (21): 15906-15911.PubMed
117.
Prasad R, Beard WA, Wilson SH: Studies of gapped DNA substrate binding by mammalian DNA polymerase beta. Dependence on 5'-phosphate group. J Biol Chem. 1994, 269 (27): 18096-18101.PubMed
118.
Matsumoto Y, Kim K: Excision of deoxyribose phosphate residues by DNA polymerase beta during DNA repair. Science. 1995, 269 (5224): 699-702.PubMed
119.
Dianov GL, Prasad R, Wilson SH, Bohr VA: Role of DNA polymerase beta in the excision step of long patch mammalian base excision repair. J Biol Chem. 1999, 274 (20): 13741-13743.PubMed
120.
Biade S, Sobol RW, Wilson SH, Matsumoto Y: Impairment of proliferating cell nuclear antigen-dependent apurinic/apyrimidinic site repair on linear DNA. J Biol Chem. 1998, 273 (2): 898-902.PubMed
121.
Sobol RW, Horton JK, Kuhn R, Gu H, Singhal RK, Prasad R, Rajewsky K, Wilson SH: Requirement of mammalian DNA polymerase-beta in base-excision repair. Nature. 1996, 379 (6561): 183-186.PubMed
122.
Hoffmann JS, Pillaire MJ, Maga G, Podust V, Hubscher U, Villani G: DNA polymerase beta bypasses in vitro a single d(GpG)-cisplatin adduct placed on codon 13 of the HRAS gene. Proc Natl Acad Sci USA. 1995, 92 (12): 5356-5360.PubMedCentralPubMed
123.
Esposito G, Texido G, Betz UA, Gu H, Muller W, Klein U, Rajewsky K: Mice reconstituted with DNA polymerase beta-deficient fetal liver cells are able to mount a T cell-dependent immune response and mutate their Ig genes normally. Proc Natl Acad Sci USA. 2000, 97 (3): 1166-1171.PubMedCentralPubMed
124.
Gu H, Marth JD, Orban PC, Mossmann H, Rajewsky K: Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 1994, 265 (5168): 103-106.PubMed
125.
Horton JK, Srivastava DK, Zmudzka BZ, Wilson SH: Strategic down-regulation of DNA polymerase beta by antisense RNA sensitizes mammalian cells to specific DNA damaging agents. Nucleic acids research. 1995, 23 (19): 3810-3815.PubMedCentralPubMed
126.
Horton JK, Baker A, Berg BJ, Sobol RW, Wilson SH: Involvement of DNA polymerase beta in protection against the cytotoxicity of oxidative DNA damage. DNA repair. 2002, 1 (4): 317-333.PubMed
127.
Sobol RW, Watson DE, Nakamura J, Yakes FM, Hou E, Horton JK, Ladapo J, Van Houten B, Swenberg JA, Tindall KR: Mutations associated with base excision repair deficiency and methylation-induced genotoxic stress. Proc Natl Acad Sci USA. 2002, 99 (10): 6860-6865.PubMedCentralPubMed
128.
Sobol RW, Prasad R, Evenski A, Baker A, Yang XP, Horton JK, Wilson SH: The lyase activity of the DNA repair protein beta-polymerase protects from DNA-damage-induced cytotoxicity. Nature. 2000, 405 (6788): 807-810.PubMed
129.
Bergoglio V, Pillaire MJ, Lacroix-Triki M, Raynaud-Messina B, Canitrot Y, Bieth A, Gares M, Wright M, Delsol G, Loeb LA: Deregulated DNA polymerase beta induces chromosome instability and tumorigenesis. Cancer Res. 2002, 62 (12): 3511-3514.PubMed
130.
Canitrot Y, Laurent G, Astarie-Dequeker C, Bordier C, Cazaux C, Hoffmann JS: Enhanced expression and activity of DNA polymerase beta in chronic myelogenous leukemia. Anticancer Res. 2006, 26 (1B): 523-525.PubMed
131.
Garcia-Diaz M, Bebenek K, Sabariegos R, Dominguez O, Rodriguez J, Kirchhoff T, Garcia-Palomero E, Picher AJ, Juarez R, Ruiz JF: DNA polymerase lambda, a novel DNA repair enzyme in human cells. J Biol Chem. 2002, 277 (15): 13184-13191.PubMed
132.
Yu X, Chini CC, He M, Mer G, Chen J: The BRCT domain is a phospho-protein binding domain. Science. 2003, 302 (5645): 639-642.PubMed
133.
Ramadan K, Maga G, Shevelev IV, Villani G, Blanco L, Hubscher U: Human DNA polymerase lambda possesses terminal deoxyribonucleotidyl transferase activity and can elongate RNA primers: implications for novel functions. J Mol Biol. 2003, 328 (1): 63-72.PubMed
134.
Bebenek K, Garcia-Diaz M, Blanco L, Kunkel TA: The frameshift infidelity of human DNA polymerase lambda. Implications for function. J Biol Chem. 2003, 278 (36): 34685-34690.PubMed
135.
Picher AJ, Garcia-Diaz M, Bebenek K, Pedersen LC, Kunkel TA, Blanco L: Promiscuous mismatch extension by human DNA polymerase lambda. Nucleic acids research. 2006, 34 (11): 3259-3266.PubMedCentralPubMed
136.
Ma Y, Lu H, Tippin B, Goodman MF, Shimazaki N, Koiwai O, Hsieh CL, Schwarz K, Lieber MR: A biochemically defined system for mammalian nonhomologous DNA end joining. Molecular cell. 2004, 16 (5): 701-713.PubMed
137.
Terrados G, Capp JP, Canitrot Y, Garcia-Diaz M, Bebenek K, Kirchhoff T, Villanueva A, Boudsocq F, Bergoglio V, Cazaux C: Characterization of a natural mutator variant of human DNA polymerase lambda which promotes chromosomal instability by compromising NHEJ. PLoS One. 2009, 4 (10): e7290-PubMedCentralPubMed
138.
Garcia-Diaz M, Bebenek K, Kunkel TA, Blanco L: Identification of an intrinsic 5'-deoxyribose-5-phosphate lyase activity in human DNA polymerase lambda: a possible role in base excision repair. J Biol Chem. 2001, 276 (37): 34659-34663.PubMed
139.
Zhang Y, Wu X, Yuan F, Xie Z, Wang Z: Highly frequent frameshift DNA synthesis by human DNA polymerase mu. Mol Cell Biol. 2001, 21 (23): 7995-8006.PubMedCentralPubMed
140.
Gu J, Lu H, Tippin B, Shimazaki N, Goodman MF, Lieber MR: XRCC4:DNA ligase IV can ligate incompatible DNA ends and can ligate across gaps. The EMBO journal. 2007, 26 (4): 1010-1023.PubMedCentralPubMed
141.
Nair DT, Johnson RE, Prakash S, Prakash L, Aggarwal AK: Replication by human DNA polymerase-iota occurs by Hoogsteen base-pairing. Nature. 2004, 430 (6997): 377-380.PubMed
142.
Uljon SN, Johnson RE, Edwards TA, Prakash S, Prakash L, Aggarwal AK: Crystal structure of the catalytic core of human DNA polymerase kappa. Structure. 2004, 12 (8): 1395-1404.PubMed
143.
Silvian LF, Toth EA, Pham P, Goodman MF, Ellenberger T: Crystal structure of a DinB family error-prone DNA polymerase from Sulfolobus solfataricus. Nat Struct Biol. 2001, 8 (11): 984-989.PubMed
144.
Trincao J, Johnson RE, Escalante CR, Prakash S, Prakash L, Aggarwal AK: Structure of the catalytic core of S. cerevisiae DNA polymerase eta: implications for translesion DNA synthesis. Molecular cell. 2001, 8 (2): 417-426.PubMed
145.
Bienko M, Green CM, Crosetto N, Rudolf F, Zapart G, Coull B, Kannouche P, Wider G, Peter M, Lehmann AR: Ubiquitin-binding domains in Y-family polymerases regulate translesion synthesis. Science. 2005, 310 (5755): 1821-1824.PubMed
146.
Ohashi E, Murakumo Y, Kanjo N, Akagi J, Masutani C, Hanaoka F, Ohmori H: Interaction of hREV1 with three human Y-family DNA polymerases. Genes Cells. 2004, 9 (6): 523-531.PubMed
147.
Lawrence CW: Cellular functions of DNA polymerase zeta and Rev1 protein. Adv Protein Chem. 2004, 69: 167-203.PubMed
148.
Guo C, Tang TS, Bienko M, Parker JL, Bielen AB, Sonoda E, Takeda S, Ulrich HD, Dikic I, Friedberg EC: Ubiquitin-binding motifs in REV1 protein are required for its role in the tolerance of DNA damage. Mol Cell Biol. 2006, 26 (23): 8892-8900.PubMedCentralPubMed
149.
Tissier A, Kannouche P, Reck MP, Lehmann AR, Fuchs RP, Cordonnier A: Co-localization in replication foci and interaction of human Y-family members, DNA polymerase pol eta and REVl protein. DNA repair. 2004, 3 (11): 1503-1514.PubMed
150.
Guo C, Sonoda E, Tang TS, Parker JL, Bielen AB, Takeda S, Ulrich HD, Friedberg EC: REV1 protein interacts with PCNA: significance of the REV1 BRCT domain in vitro and in vivo. Molecular cell. 2006, 23 (2): 265-271.PubMed
151.
Simpson LJ, Sale JE: Rev1 is essential for DNA damage tolerance and non-templated immunoglobulin gene mutation in a vertebrate cell line. The EMBO journal. 2003, 22 (7): 1654-1664.PubMedCentralPubMed
152.
Sarkies P, Reams C, Simpson LJ, Sale JE: Epigenetic Instability due to Defective Replication of Structured DNA. Molecular cell. 2010, 40 (5): 703-713.PubMedCentralPubMed
153.
Masutani C, Kusumoto R, Yamada A, Dohmae N, Yokoi M, Yuasa M, Araki M, Iwai S, Takio K, Hanaoka F: The XPV (xeroderma pigmentosum variant) gene encodes human DNA polymerase eta. Nature. 1999, 399 (6737): 700-704.PubMed
154.
Acharya N, Yoon JH, Gali H, Unk I, Haracska L, Johnson RE, Hurwitz J, Prakash L, Prakash S: Roles of PCNA-binding and ubiquitin-binding domains in human DNA polymerase eta in translesion DNA synthesis. Proc Natl Acad Sci USA. 2008, 105 (46): 17724-17729.PubMedCentralPubMed
155.
Yagi Y, Ogawara D, Iwai S, Hanaoka F, Akiyama M, Maki H: DNA polymerases eta and kappa are responsible for error-free translesion DNA synthesis activity over a cis-syn thymine dimer in Xenopus laevis oocyte extracts. DNA repair. 2005, 4 (11): 1252-1269.PubMed
156.
Wang Y, Woodgate R, McManus TP, Mead S, McCormick JJ, Maher VM: Evidence that in xeroderma pigmentosum variant cells, which lack DNA polymerase eta, DNA polymerase iota causes the very high frequency and unique spectrum of UV-induced mutations. Cancer Res. 2007, 67 (7): 3018-3026.PubMed
157.
Jansen JG, Tsaalbi-Shtylik A, Langerak P, Calleja F, Meijers CM, Jacobs H, de Wind N: The BRCT domain of mammalian Rev1 is involved in regulating DNA translesion synthesis. Nucleic acids research. 2005, 33 (1): 356-365.PubMedCentralPubMed
158.
Delbos F, De Smet A, Faili A, Aoufouchi S, Weill JC, Reynaud CA: Contribution of DNA polymerase eta to immunoglobulin gene hypermutation in the mouse. J Exp Med. 2005, 201 (8): 1191-1196.PubMedCentralPubMed
159.
Ogi T, Kannouche P, Lehmann AR: Localisation of human Y-family DNA polymerase kappa: relationship to PCNA foci. J Cell Sci. 2005, 118 (Pt 1): 129-136.PubMed
160.
Ziv O, Geacintov N, Nakajima S, Yasui A, Livneh Z: DNA polymerase zeta cooperates with polymerases kappa and iota in translesion DNA synthesis across pyrimidine photodimers in cells from XPV patients. Proc Natl Acad Sci USA. 2009, 106 (28): 11552-11557.PubMedCentralPubMed
161.
Ogi T, Limsirichaikul S, Overmeer RM, Volker M, Takenaka K, Cloney R, Nakazawa Y, Niimi A, Miki Y, Jaspers NG: Three DNA polymerases, recruited by different mechanisms, carry out NER repair synthesis in human cells. Molecular cell. 2010, 37 (5): 714-727.PubMed
162.
Bavoux C, Leopoldino AM, Bergoglio V, J OW, Ogi T, Bieth A, Judde JG, Pena SD, Poupon MF, Helleday T: Up-regulation of the error-prone DNA polymerase {kappa} promotes pleiotropic genetic alterations and tumorigenesis. Cancer Res. 2005, 65 (1): 325-330.PubMed
163.
Bebenek K, Tissier A, Frank EG, McDonald JP, Prasad R, Wilson SH, Woodgate R, Kunkel TA: 5'-Deoxyribose phosphate lyase activity of human DNA polymerase iota in vitro. Science. 2001, 291 (5511): 2156-2159.PubMed
164.
Petta TB, Nakajima S, Zlatanou A, Despras E, Couve-Privat S, Ishchenko A, Sarasin A, Yasui A, Kannouche P: Human DNA polymerase iota protects cells against oxidative stress. The EMBO journal. 2008, 27 (21): 2883-2895.PubMedCentralPubMed
165.
Kannouche P, Fernandez de Henestrosa AR, Coull B, Vidal AE, Gray C, Zicha D, Woodgate R, Lehmann AR: Localization of DNA polymerases eta and iota to the replication machinery is tightly co-ordinated in human cells. The EMBO journal. 2003, 22 (5): 1223-1233.PubMedCentralPubMed
166.
Kannouche PL, Wing J, Lehmann AR: Interaction of human DNA polymerase eta with monoubiquitinated PCNA: a possible mechanism for the polymerase switch in response to DNA damage. Molecular cell. 2004, 14 (4): 491-500.PubMed
167.
Watanabe K, Tateishi S, Kawasuji M, Tsurimoto T, Inoue H, Yamaizumi M: Rad18 guides poleta to replication stalling sites through physical interaction and PCNA monoubiquitination. The EMBO journal. 2004, 23 (19): 3886-3896.PubMedCentralPubMed
168.
Andersen PL, Xu F, Xiao W: Eukaryotic DNA damage tolerance and translesion synthesis through covalent modifications of PCNA. Cell Res. 2008, 18 (1): 162-173.PubMed
169.
170.
Unk I, Hajdu I, Fatyol K, Szakal B, Blastyak A, Bermudez V, Hurwitz J, Prakash L, Prakash S, Haracska L: Human SHPRH is a ubiquitin ligase for Mms2-Ubc13-dependent polyubiquitylation of proliferating cell nuclear antigen. Proc Natl Acad Sci USA. 2006, 103 (48): 18107-18112.PubMedCentralPubMed
171.
Unk I, Hajdu I, Fatyol K, Hurwitz J, Yoon JH, Prakash L, Prakash S, Haracska L: Human HLTF functions as a ubiquitin ligase for proliferating cell nuclear antigen polyubiquitination. Proc Natl Acad Sci USA. 2008, 105 (10): 3768-3773.PubMedCentralPubMed
172.
Ulrich HD: Deubiquitinating PCNA: a downside to DNA damage tolerance. Nat Cell Biol. 2006, 8 (4): 303-305.PubMed
173.
Huang TT, Nijman SM, Mirchandani KD, Galardy PJ, Cohn MA, Haas W, Gygi SP, Ploegh HL, Bernards R, D'Andrea AD: Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat Cell Biol. 2006, 8 (4): 339-347.PubMed
174.
Wang W: Emergence of a DNA-damage response network consisting of Fanconi anaemia and BRCA proteins. Nat Rev Genet. 2007, 8 (10): 735-748.PubMed
175.
Hicks JK, Chute CL, Paulsen MT, Ragland RL, Howlett NG, Gueranger Q, Glover TW, Canman CE: Differential roles for DNA polymerases eta, zeta, and REV1 in lesion bypass of intrastrand versus interstrand DNA cross-links. Mol Cell Biol. 30 (5): 1217-1230.
176.
Mirchandani KD, McCaffrey RM, D'Andrea AD: The Fanconi anemia core complex is required for efficient point mutagenesis and Rev1 foci assembly. DNA repair. 2008, 7 (6): 902-911.PubMedCentralPubMed
177.
Sabbioneda S, Minesinger BK, Giannattasio M, Plevani P, Muzi-Falconi M, Jinks-Robertson S: The 9-1-1 checkpoint clamp physically interacts with polzeta and is partially required for spontaneous polzeta-dependent mutagenesis in Saccharomyces cerevisiae. J Biol Chem. 2005, 280 (46): 38657-38665.PubMed
178.
Friedberg EC, Lehmann AR, Fuchs RP: Trading places: how do DNA polymerases switch during translesion DNA synthesis?. Molecular cell. 2005, 18 (5): 499-505.PubMed
179.
Lopes M, Foiani M, Sogo JM: Multiple mechanisms control chromosome integrity after replication fork uncoupling and restart at irreparable UV lesions. Molecular cell. 2006, 21 (1): 15-27.PubMed
180.
Waters LS, Walker GC: The critical mutagenic translesion DNA polymerase Rev1 is highly expressed during G(2)/M phase rather than S phase. Proc Natl Acad Sci USA. 2006, 103 (24): 8971-8976.PubMedCentralPubMed
181.
Jansen JG, Tsaalbi-Shtylik A, Hendriks G, Verspuy J, Gali H, Haracska L, de Wind N: Mammalian polymerase zeta is essential for post-replication repair of UV-induced DNA lesions. DNA repair. 2009, 8 (12): 1444-1451.PubMed
182.
Edmunds CE, Simpson LJ, Sale JE: PCNA ubiquitination and REV1 define temporally distinct mechanisms for controlling translesion synthesis in the avian cell line DT40. Molecular cell. 2008, 30 (4): 519-529.PubMed
183.
Fung H, Demple B: Distinct roles of Ape1 protein in the repair of DNA damage induced by ionizing radiation or bleomycin. J Biol Chem. 2011, 286 (7): 4968-4977.PubMedCentralPubMed
184.
Blanca G, Villani G, Shevelev I, Ramadan K, Spadari S, Hubscher U, Maga G: Human DNA polymerases lambda and beta show different efficiencies of translesion DNA synthesis past abasic sites and alternative mechanisms for frameshift generation. Biochemistry. 2004, 43 (36): 11605-11615.PubMed
185.
Efrati E, Tocco G, Eritja R, Wilson SH, Goodman MF: Abasic translesion synthesis by DNA polymerase beta violates the "A-rule". Novel types of nucleotide incorporation by human DNA polymerase beta at an abasic lesion in different sequence contexts. J Biol Chem. 1997, 272 (4): 2559-2569.PubMed
186.
Masutani C, Kusumoto R, Iwai S, Hanaoka F: Mechanisms of accurate translesion synthesis by human DNA polymerase eta. The EMBO journal. 2000, 19 (12): 3100-3109.PubMedCentralPubMed
187.
Ramadan K, Shevelev IV, Maga G, Hubscher U: DNA polymerase lambda from calf thymus preferentially replicates damaged DNA. J Biol Chem. 2002, 277 (21): 18454-18458.PubMed
188.
Maga G, Villani G, Ramadan K, Shevelev I, Tanguy Le Gac N, Blanco L, Blanca G, Spadari S, Hubscher U: Human DNA polymerase lambda functionally and physically interacts with proliferating cell nuclear antigen in normal and translesion DNA synthesis. J Biol Chem. 2002, 277 (50): 48434-48440.PubMed
189.
Ohashi E, Ogi T, Kusumoto R, Iwai S, Masutani C, Hanaoka F, Ohmori H: Error-prone bypass of certain DNA lesions by the human DNA polymerase kappa. Genes Dev. 2000, 14 (13): 1589-1594.PubMedCentralPubMed
190.
Zhang Y, Wu X, Guo D, Rechkoblit O, Taylor JS, Geacintov NE, Wang Z: Lesion bypass activities of human DNA polymerase mu. J Biol Chem. 2002, 277 (46): 44582-44587.PubMed
191.
Choi JY, Lim S, Kim EJ, Jo A, Guengerich FP: Translesion synthesis across abasic lesions by human B-family and Y-family DNA polymerases alpha, delta, eta, iota, kappa, and REV1. J Mol Biol. 2010, 404 (1): 34-44.PubMedCentralPubMed
192.
Croteau DL, Bohr VA: Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J Biol Chem. 1997, 272 (41): 25409-25412.PubMed
193.
Lindahl T: Instability and decay of the primary structure of DNA. Nature. 1993, 362 (6422): 709-715.PubMed
194.
Olinski R, Zastawny T, Budzbon J, Skokowski J, Zegarski W, Dizdaroglu M: DNA base modifications in chromatin of human cancerous tissues. FEBS Lett. 1992, 309 (2): 193-198.PubMed
195.
Avkin S, Livneh Z: Efficiency, specificity and DNA polymerase-dependence of translesion replication across the oxidative DNA lesion 8-oxoguanine in human cells. Mutation research. 2002, 510 (1-2): 81-90.PubMed
196.
Irimia A, Eoff RL, Guengerich FP, Egli M: Structural and functional elucidation of the mechanism promoting error-prone synthesis by human DNA polymerase kappa opposite the 7, 8-dihydro-8-oxo-2'-deoxyguanosine adduct. J Biol Chem. 2009, 284 (33): 22467-22480.PubMedCentralPubMed
197.
Zhang Y, Yuan F, Wu X, Taylor JS, Wang Z: Response of human DNA polymerase iota to DNA lesions. Nucleic acids research. 2001, 29 (4): 928-935.PubMedCentralPubMed
198.
Maga G, Villani G, Crespan E, Wimmer U, Ferrari E, Bertocci B, Hubscher U: 8-oxo-guanine bypass by human DNA polymerases in the presence of auxiliary proteins. Nature. 2007, 447 (7144): 606-608.PubMed
199.
Maga G, Crespan E, Wimmer U, van Loon B, Amoroso A, Mondello C, Belgiovine C, Ferrari E, Locatelli G, Villani G: Replication protein A and proliferating cell nuclear antigen coordinate DNA polymerase selection in 8-oxo-guanine repair. Proc Natl Acad Sci USA. 2008, 105 (52): 20689-20694.PubMedCentralPubMed
200.
Belousova EA, Maga G, Fan Y, Kubareva EA, Romanova EA, Lebedeva NA, Oretskaya TS, Lavrik OI: DNA polymerases beta and lambda bypass thymine glycol in gapped DNA structures. Biochemistry. 2010, 49 (22): 4695-4704.PubMed
201.
Yoon JH, Bhatia G, Prakash S, Prakash L: Error-free replicative bypass of thymine glycol by the combined action of DNA polymerases kappa and zeta in human cells. Proc Natl Acad Sci USA. 2010, 107 (32): 14116-14121.PubMedCentralPubMed
202.
Lindahl T, Wood RD: Quality control by DNA repair. Science. 1999, 286 (5446): 1897-1905.PubMed
203.
Hoeijmakers JH: DNA damage, aging, and cancer. N Engl J Med. 2009, 361 (15): 1475-1485.PubMed
204.
Kim JK, Patel D, Choi BS: Contrasting structural impacts induced by cis-syn cyclobutane dimer and (6-4) adduct in DNA duplex decamers: implication in mutagenesis and repair activity. Photochem Photobiol. 1995, 62 (1): 44-50.PubMed
205.
Yoon JH, Prakash L, Prakash S: Error-free replicative bypass of (6-4) photoproducts by DNA polymerase zeta in mouse and human cells. Genes Dev. 2010, 24 (2): 123-128.PubMedCentralPubMed
206.
Park H, Zhang K, Ren Y, Nadji S, Sinha N, Taylor JS, Kang C: Crystal structure of a DNA decamer containing a cis-syn thymine dimer. Proc Natl Acad Sci USA. 2002, 99 (25): 15965-15970.PubMedCentralPubMed
207.
Johnson RE, Washington MT, Prakash S, Prakash L: Fidelity of human DNA polymerase eta. J Biol Chem. 2000, 275 (11): 7447-7450.PubMed
208.
McCulloch SD, Kokoska RJ, Masutani C, Iwai S, Hanaoka F, Kunkel TA: Preferential cis-syn thymine dimer bypass by DNA polymerase eta occurs with biased fidelity. Nature. 2004, 428 (6978): 97-100.PubMed
209.
Hendel A, Ziv O, Gueranger Q, Geacintov N, Livneh Z: Reduced efficiency and increased mutagenicity of translesion DNA synthesis across a TT cyclobutane pyrimidine dimer, but not a TT 6-4 photoproduct, in human cells lacking DNA polymerase eta. DNA repair. 2008, 7 (10): 1636-1646.PubMedCentralPubMed
210.
Denissenko MF, Pao A, Tang M, Pfeifer GP: Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science. 1996, 274 (5286): 430-432.PubMed
211.
Avkin S, Goldsmith M, Velasco-Miguel S, Geacintov N, Friedberg EC, Livneh Z: Quantitative analysis of translesion DNA synthesis across a benzo[a]pyrene-guanine adduct in mammalian cells: the role of DNA polymerase kappa. J Biol Chem. 2004, 279 (51): 53298-53305.PubMed
212.
Vaisman A, Chaney SG: The efficiency and fidelity of translesion synthesis past cisplatin and oxaliplatin GpG adducts by human DNA polymerase beta. J Biol Chem. 2000, 275 (17): 13017-13025.PubMed
213.
Vaisman A, Masutani C, Hanaoka F, Chaney SG: Efficient translesion replication past oxaliplatin and cisplatin GpG adducts by human DNA polymerase eta. Biochemistry. 2000, 39 (16): 4575-4580.PubMed
214.
Vaisman A, Lim SE, Patrick SM, Copeland WC, Hinkle DC, Turchi JJ, Chaney SG: Effect of DNA polymerases and high mobility group protein 1 on the carrier ligand specificity for translesion synthesis past platinum-DNA adducts. Biochemistry. 1999, 38 (34): 11026-11039.PubMed
215.
Havener JM, Nick McElhinny SA, Bassett E, Gauger M, Ramsden DA, Chaney SG: Translesion synthesis past platinum DNA adducts by human DNA polymerase mu. Biochemistry. 2003, 42 (6): 1777-1788.PubMed
216.
217.
Stone MP, Cho YJ, Huang H, Kim HY, Kozekov ID, Kozekova A, Wang H, Minko IG, Lloyd RS, Harris TM: Interstrand DNA cross-links induced by alpha, beta-unsaturated aldehydes derived from lipid peroxidation and environmental sources. Acc Chem Res. 2008, 41 (7): 793-804.PubMedCentralPubMed
218.
Minko IG, Harbut MB, Kozekov ID, Kozekova A, Jakobs PM, Olson SB, Moses RE, Harris TM, Rizzo CJ, Lloyd RS: Role for DNA polymerase kappa in the processing of N2-N2-guanine interstrand cross-links. J Biol Chem. 2008, 283 (25): 17075-17082.PubMedCentralPubMed
219.
Albertella MR, Green CM, Lehmann AR, O'Connor MJ: A role for polymerase eta in the cellular tolerance to cisplatin-induced damage. Cancer Res. 2005, 65 (21): 9799-9806.PubMed
220.
Chen YW, Cleaver JE, Hanaoka F, Chang CF, Chou KM: A novel role of DNA polymerase eta in modulating cellular sensitivity to chemotherapeutic agents. Mol Cancer Res. 2006, 4 (4): 257-265.PubMed
221.
Shen X, Jun S, O'Neal LE, Sonoda E, Bemark M, Sale JE, Li L: REV3 and REV1 play major roles in recombination-independent repair of DNA interstrand cross-links mediated by monoubiquitinated proliferating cell nuclear antigen (PCNA). J Biol Chem. 2006, 281 (20): 13869-13872.PubMed
222.
Raschle M, Knipscheer P, Enoiu M, Angelov T, Sun J, Griffith JD, Ellenberger TE, Scharer OD, Walter JC: Mechanism of replication-coupled DNA interstrand crosslink repair. Cell. 2008, 134 (6): 969-980.PubMedCentralPubMed
223.
Masuda Y, Ohmae M, Masuda K, Kamiya K: Structure and enzymatic properties of a stable complex of the human REV1 and REV7 proteins. J Biol Chem. 2003, 278 (14): 12356-12360.PubMed
224.
Hlavin EM, Smeaton MB, Noronha AM, Wilds CJ, Miller PS: Cross-link structure affects replication-independent DNA interstrand cross-link repair in mammalian cells. Biochemistry. 2010, 49 (18): 3977-3988.PubMedCentralPubMed
225.
Quah SK, von Borstel RC, Hastings PJ: The origin of spontaneous mutation in Saccharomyces cerevisiae. Genetics. 1980, 96 (4): 819-839.PubMedCentralPubMed
226.
Starcevic D, Dalal S, Sweasy JB: Is there a link between DNA polymerase beta and cancer?. Cell Cycle. 2004, 3 (8): 998-1001.PubMed
227.
Lee GH, Matsushita H: Genetic linkage between Pol iota deficiency and increased susceptibility to lung tumors in mice. Cancer Sci. 2005, 96 (5): 256-259.PubMed
228.
Wang M, Devereux TR, Vikis HG, McCulloch SD, Holliday W, Anna C, Wang Y, Bebenek K, Kunkel TA, Guan K: Pol iota is a candidate for the mouse pulmonary adenoma resistance 2 locus, a major modifier of chemically induced lung neoplasia. Cancer Res. 2004, 64 (6): 1924-1931.PubMed
229.
Sakiyama T, Kohno T, Mimaki S, Ohta T, Yanagitani N, Sobue T, Kunitoh H, Saito R, Shimizu K, Hirama C: Association of amino acid substitution polymorphisms in DNA repair genes TP53, POLI, REV1 and LIG4 with lung cancer risk. Int J Cancer. 2005, 114 (5): 730-737.PubMed
230.
Albertella MR, Lau A, O'Connor MJ: The overexpression of specialized DNA polymerases in cancer. DNA repair. 2005, 4 (5): 583-593.PubMed
231.
J OW, Kawamura K, Tada Y, Ohmori H, Kimura H, Sakiyama S, Tagawa M: DNA polymerase kappa, implicated in spontaneous and DNA damage-induced mutagenesis, is overexpressed in lung cancer. Cancer Res. 2001, 61 (14): 5366-5369.
232.
Yang J, Chen Z, Liu Y, Hickey RJ, Malkas LH: Altered DNA polymerase iota expression in breast cancer cells leads to a reduction in DNA replication fidelity and a higher rate of mutagenesis. Cancer Res. 2004, 64 (16): 5597-5607.PubMed
233.
Lemee F, Bergoglio V, Fernandez-Vidal A, Machado-Silva A, Pillaire MJ, Bieth A, Gentil C, Baker L, Martin AL, Leduc C: DNA polymerase theta up-regulation is associated with poor survival in breast cancer, perturbs DNA replication, and promotes genetic instability. Proc Natl Acad Sci USA. 2010, 107 (30): 13390-13395.PubMedCentralPubMed
234.
Bartkova J, Horejsi Z, Koed K, Kramer A, Tort F, Zieger K, Guldberg P, Sehested M, Nesland JM, Lukas C: DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005, 434 (7035): 864-870.PubMed
235.
Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ: Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med. 2009, 361 (2): 123-134.PubMed
236.
Martin SA, McCabe N, Mullarkey M, Cummins R, Burgess DJ, Nakabeppu Y, Oka S, Kay E, Lord CJ, Ashworth A: DNA polymerases as potential therapeutic targets for cancers deficient in the DNA mismatch repair proteins MSH2 or MLH1. Cancer cell. 2010, 17 (3): 235-248.PubMedCentralPubMed
237.
Knobel PA, Kotov IN, Felley-Bosco E, Stahel RA, Marti TM: Inhibition of REV3 expression induces persistent DNA damage and growth arrest in cancer cells. Neoplasia (New York, NY. 2011, 13 (10): 961-970.
238.
Wang Z: DNA damage-induced mutagenesis: a novel target for cancer prevention. Mol Interv. 2001, 1 (5): 269-281.PubMed
239.
Northam MR, Robinson HA, Kochenova OV, Shcherbakova PV: Participation of DNA polymerase zeta in replication of undamaged DNA in Saccharomyces cerevisiae. Genetics. 2010, 184 (1): 27-42.PubMedCentralPubMed
240.
Izuta S: Inhibition of DNA polymerase eta by oxetanocin derivatives. Nucleic Acids Symp Ser (Oxf). 2006, 269-270. 50
241.
Mizushina Y, Kamisuki S, Kasai N, Ishidoh T, Shimazaki N, Takemura M, Asahara H, Linn S, Yoshida S, Koiwai O: Petasiphenol: a DNA polymerase lambda inhibitor. Biochemistry. 2002, 41 (49): 14463-14471.PubMed
242.
Matsubara K, Mori M, Mizushina Y: Petasiphenol which inhibits DNA polymerase lambda activity is an inhibitor of in vitro angiogenesis. Oncol Rep. 2004, 11 (2): 447-451.PubMed
243.
Maga G, Hubscher U: Repair and translesion DNA polymerases as anticancer drug targets. Anticancer Agents Med Chem. 2008, 8 (4): 431-447.PubMed
244.
Degregori J: Evolved tumor suppression: why are we so good at not getting cancer?. Cancer Res. 2011, 71 (11): 3739-3744.PubMedCentralPubMed
245.
Waters LS, Minesinger BK, Wiltrout ME, D'Souza S, Woodruff RV, Walker GC: Eukaryotic translesion polymerases and their roles and regulation in DNA damage tolerance. Microbiol Mol Biol Rev. 2009, 73 (1): 134-154.PubMedCentralPubMed
246.
247.
Livneh Z, Ziv O, Shachar S: Multiple two-polymerase mechanisms in mammalian translesion DNA synthesis. Cell Cycle. 2010, 9 (4): 729-735.PubMed
Metadata
Title
Translesion DNA synthesis in the context of cancer research
Authors
Philip A Knobel
Thomas M Marti
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Cancer Cell International / Issue 1/2011
Electronic ISSN: 1475-2867
DOI
https://doi.org/10.1186/1475-2867-11-39

Other articles of this Issue 1/2011

Cancer Cell International 1/2011 Go to the issue

Primary research

In vitro activities of novel 4-HPR derivatives on a panel of rhabdoid and other tumor cell lines

Primary research

Targeting different types of human meningioma and glioma cells using a novel adenoviral vector expressing GFP-TRAIL fusion protein from hTERT promoter

Review

A short account of metastatic bone disease

Review

Therapeutics formulated to target cancer stem cells: Is it in our future?

Primary research

Involvement of the epidermal growth factor receptor in the modulation of multidrug resistance in human hepatocellular carcinoma cells in vitro

Primary research

Cell fusion in tumor progression: the isolation of cell fusion products by physical methods
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits